The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Antibiotic therapy and association with oncological outcomes from targeted and immune-based therapy in hepatocellular carcinoma (HCC).
 
David J. James Pinato
Honoraria - Avammune; Bristol-Myers Squibb; Da Volterra; Mursla Bio; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Da Volterra; Eisai; H3 Biomedicine; Ipsen; Mina Therapeutics; Roche
Speakers' Bureau - Bayer; Falk Pharma; Roche; ViiV Healthcare
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; MSD Oncology
Other Relationship - Wiley
 
Xiaoxue Li
No Relationships to Disclose
 
Pallavi Shruti Mishra-Kalyani
No Relationships to Disclose
 
Antonio D'Alessio
No Relationships to Disclose
 
Claudia A.M. Fulgenzi
No Relationships to Disclose
 
Guo Wei
No Relationships to Disclose
 
Julie A. Schneider
No Relationships to Disclose
 
Donna Rivera
No Relationships to Disclose
 
Richard Pazdur
No Relationships to Disclose
 
Marc Robert Theoret
No Relationships to Disclose
 
Sandra J. Casak
No Relationships to Disclose
 
Steven Lemery
No Relationships to Disclose
 
Ibilola Fashoyin
No Relationships to Disclose
 
Alessio Cortellini
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Roche
Speakers' Bureau - AstraZeneca; Eisai
 
Lorraine Cheryl Pelosof
No Relationships to Disclose